Prescription drug · ANDA
Atenolol NDC 83980-023
Atenolol 50 mg/1 · Tablet · Oral · Ipca Laboratories Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83980-023-01 | 83980002301 | 100 TABLET in 1 BOTTLE (83980-023-01)Marketed from Jan 30, 2026 | |
| 83980-023-10 | 83980002310 | 1000 TABLET in 1 BOTTLE (83980-023-10)Marketed from Jan 30, 2026 | |
| 83980-023-97 | 83980002397 | 10 TABLET in 1 BOTTLE (83980-023-97)Marketed from Jan 30, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Atenolol
- Generic name (nonproprietary)
- atenolol
- Active ingredients
- Atenolol — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Ipca Laboratories Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077877
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 83980-023_d32b777e-6c64-4899-934b-4fb73d9eba85SPL ID d32b777e-6c64-4899-934b-4fb73d9eba85SPL set ID 98d29958-b026-4888-a516-7bb85bb7d479RxCUI 197379, 197380, 197381UNII 50VV3VW0TI
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N483980002301followed by a unit qualifier and the quantityPackage 83980-0023-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Hypertension Atenolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood p…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077877
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.